Elamipretide in pediatric Barth syndrome: from heart failure to school return

Orphanet J Rare Dis. 2026 Jul 7. doi: 10.1186/s13023-026-04487-z. Online ahead of print.ABSTRACTBACKGROUND: Barth syndrome (BTHS) is a rare X-linked mitochondrial disorder characterized by cardiomyopathy, neutropenia, and skeletal myopathy. Elamipretide is a mitochondria-targeting peptide that stabi

P Pascal Amedro

Territorial heterogeneity of atherosclerosis and vascular calcification

Nat Cardiovasc Res. 2026 Jul 7. doi: 10.1038/s44161-026-00832-4. Online ahead of print.ABSTRACTAtherosclerosis is a systemic disease of the arterial tree that often assumes variable forms across vascular territories. As a result, atherosclerotic plaques in different vascular beds differ in frequency

L Luca Saba

Clinical outcomes of continuing vs. discontinuing oral anticoagulation after atrial fibrillation ablation: an updated systematic review and meta-analysis of observational studies and randomized controlled trials

Europace. 2026 Jul 3;28(7):euag104. doi: 10.1093/europace/euag104.ABSTRACTAIMS: Continuation of oral anticoagulation (OAC) after successful atrial fibrillation (AF) ablation remains debated. With recent randomized controlled trials addressing this question, an updated meta-analysis is needed to info

S Sandeep Samethadka Nayak

Multidimensional correlates of adherence to cardiovascular treatment among patients with multimorbidity from tribal communities in South India: an exploratory cross-sectional study

BMJ Open. 2026 Jul 7;16(7):e112120. doi: 10.1136/bmjopen-2025-112120.ABSTRACTINTRODUCTION: Tribal people in India face a growing risk of multimorbidity, primarily from cardiovascular diseases (CVD) due to changing lifestyles and unique socio-cultural and political factors. We aimed to identify treat

D Deepa Srinivasan

Clinical, procedural and patient-reported outcomes of the Ultimaster Nagomi sirolimus-eluting coronary stent in complex percutaneous coronary intervention: the NAGOMI COMPLEX prospective cohort study protocol

BMJ Open. 2026 Jul 7;16(7):e116572. doi: 10.1136/bmjopen-2026-116572.ABSTRACTINTRODUCTION: Percutaneous coronary intervention (PCI) has evolved significantly over the past decade with approximately 30% of patients presenting with complex coronary artery disease, posing heightened procedural and long

M Mamas Mamas